Related Experiment Videos
Telomerase, p53 and PCNA activity in osteosarcoma
H Nakashima1, Y Nishida, H Sugiura
1Department of Orthopaedic Surgery, Nagoya University School of Medicine, Nagoya, Japan. h-nakashima@hospy.or.jp
Summary
Telomerase activity is low in most osteosarcoma cases and does not correlate with p53 overexpression. However, telomerase activity is linked to tumor proliferative activity, suggesting its potential as a biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Osteosarcoma is a primary bone cancer with variable clinical outcomes.
- Telomerase is a key enzyme in cellular immortalization, often implicated in cancer.
- The role of p53 in osteosarcoma proliferation and its interaction with telomerase requires further elucidation.
Purpose of the Study:
- To investigate telomerase activity in osteosarcoma.
- To assess the correlation between telomerase activity, p53 overexpression, and tumor proliferative activity (PCNA) in osteosarcoma.
Main Methods:
- Telomerase activity was measured using the telomeric repeat amplification protocol (TRAP) assay.
- p53 overexpression was assessed via immunohistochemical staining.
- Proliferative activity was evaluated by PCNA immunohistochemical staining.
Main Results:
- Telomerase activity was detected at low levels in only 5 of 26 osteosarcoma specimens.
- p53 overexpression was observed in 8 of 21 cases.
- No significant correlation was found between telomerase activity and p53 overexpression (p=0.325).
- A significant positive correlation was observed between PCNA staining and telomerase activity (p=0.0075).
Conclusions:
- The findings suggest that p53 and telomerase may not cooperate in osteosarcoma proliferation.
- Telomerase activity correlates with proliferative activity (PCNA) in osteosarcoma.
- Telomerase activity may serve as a useful indicator for evaluating proliferative activity in osteosarcoma.